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Background: Anemia is the most common hematological abnormalities in HIV patients and it is a wide spread
public health problem. The World Health Organization estimates that over 2 billion people are anemic worldwide
with more than 100 million of these anemic children living in Africa. In Ethiopia, there is limited information about
the prevalence and factors associated with anemia among HIV positive children. Thus, this study aimed to
determine the prevalence and associated factors of anemia among HIV infected children aged 6 months to 14
years in Gondar university Hospital antiretroviral treatment clinic.
Methods: A cross-sectional study was conducted on 265 HIV infected children from February to June 2013 on HIV
infected children attending Gondar university Hospital ART clinic. The study subjects were selected with systematic
random sampling technique. Data of socio demographic characteristics and clinical conditions of the study subjects
was collected using a structured pretested questionnaire. Hemoglobin value and CD4 counts were determined by
cell Dyne 1800 and FACS count machine respectively. WHO Cut off value of hemoglobin was taken and adjusted to
altitude to define anemia. Data was analyzed by using the SPSS version 20 statistical software and bivariate and
multivariate logistic regression was used to identify predictors.
Results: Anemia was present in 16.2 % (43 /265) of children, 60.5 % of them had mild anemia, 37.2 % had
moderate anemia and 2.3 % had severe anemia. About 46.5 % of anemic children had normocytic-normochromic
anemia followed by macrocytic-normochromic anemia (39.5 %). In this study, anemia was associated with eating
green leafy vegetables (OR = 0.43, 95 % CI (0.188–0.981) and being on cotrimoxazole treatment (OR = 2.169, 95 % CI
(1.047–4.49). But there was no significant association with age, sex, WHO clinical stage, opportunistic infections,
intestinal parasitic infection and CD4 count percentage.
Conclusions: The majority of HIV positive children in Northwest Ethiopia have a mild type of anemia and the
increase in prevalence of anemia is due to being on cotrimoxazole and eating green leafy vegetables. Therefore,
early diagnosis and treatment of anemia is essential in these patients.
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Of HIV related hematological abnormalities, anemia is
the most common hematological complication of HIV
infection that has a significant impact on the quality of
life and clinical outcomes [1]. Of patients, it is estimated
that up to 90 % of adults and children develop anemia
during HIV infection [2]. According to World Health
Organization (WHO) definitions, anemia is defined as
hemoglobin level less than 11 g/dl for children <5 years
old, <11.5 g/dl for children 5–11.9 years old and <12 g/dl
for children 12–14.9 years old after altitude adjust-
ment [3–5]. Anemia is also classified as mild degree
(Hgb 10.0–10.9 g/dl), moderate (Hgb 7.0–9.9 g/dl),
severe (Hgb 4.0–7.0 g/dl), and very severe Hgb less
than 4.0 g/dl. It can also be classified based on the
Hematocrit (PCV) percent. Packed cell volume (PCV)
of less than 33.0 % is regarded as anemia by the
World Health Organization [3, 6, 7].
Anemia has been shown to be a significant predictor
of progression to AIDS and several studies have shown
that as hemoglobin levels decrease, the risk of HIV dis-
ease progression increases [8] and it is associated with
an increased risk of death in both children and adult pa-
tients [1, 9–11]. It is a wide spread public health prob-
lem; The WHO estimates that over 2 billion people are
anemic worldwide with more than 100 million of these
anemic children living in Africa [12]. In East Africa, the
prevalence of anemia ranges from 15–93 % [13]. Accord-
ing to the 2011 Ethiopia Demographic and Health Survey
more than four in ten children (44 %) are anemic. One
child of every five (21 %) has mild anemia, another 20 %
have moderate anemia, and 3 % have severe anemia in the
country [14]. But there is limited information about preva-
lence of anemia among HIV infected children in Ethiopia.
Anemia prevalence in children with HIV depends on
several factors, such as stage of HIV infection, sex, age,
race, and concurrent illness as well as the definition of
anemia used. In general, as the HIV disease progresses,
the prevalence and severity of anemia increases [9]. The
high prevalence of anemia in HIV infected children in
developing countries may be attributed to the fact
that many of the children in these regions are also
iron deficient which is compounded by poor socio-
economic status [15, 16].
In addition to the direct effect of HIV, highly active
antiretroviral therapy (HAART) also causes anemia. Al-
though HAART has the capability of reducing the inci-
dence of anemia [17] and lymphopenia by suppressing
viral replication and increases CD4 cell count, anemia
remains a common problem even for patients treated
with antiretroviral agents. Anemia due to drugs, such
as cotrimoxazole, pentamidine, foscarnet and zidovu-
dine (AZT) often reflects reticuloendothelial iron block.
Among the antiretroviral drugs, AZT is the mostwidely used drug that results in myelosuppression and
thus anemia [18–21].
In Ethiopia, there is limited information about the
prevalence and factors associated with anemia among
HIV positive children. The study conducted in Jimma
[18] is not enough to give conclusions to the general
population. Since the normal hematological values are
different in children on HAART and HAART naive, it is
difficult to drive conclusions because the study con-
ducted in Jimma only took those children who were on
HAART. Therefore the current study determined the
prevalence and associated factors of anemia among HIV
infected children, aged 6 months to 14 years, in Gondar
university Hospital ART Clinic.
Methods
Study setting and population
An institutional based, cross-sectional study was conducted
from February to June, 2013 among 265 HIV infected chil-
dren, aged 6 months to 14 years, attending Gondar univer-
sity hospital. At the time of data collection there were 722
HIV infected children attending Gondar university hospital
ART clinic. From them 265 were selected using systematic
random sampling technique. A detailed history including,
the socio-demographic characteristics, presenting symp-
toms, presence of symptoms related to anemia, nutritional
history, past medical history, previous and current
drug history, caretaker characteristics (including edu-
cation level, occupation and income) was assessed
with a pre-tested and a standardized questionnaire.
All study subjects were approached during their re-
spective appointments for follow up. After the inter-
view, a detailed review of the medical records, such
as concurrent opportunistic infections and WHO clin-
ical staging of HIV disease was recorded. Then blood
samples for hemoglobin determination and CD4
counts and stool samples for intestinal parasite were
collected and processed.
Laboratory analysis
About 4 ml of venous blood was collected by an ex-
perienced laboratory technologist from each subject
for CD4 count and hematological parameters analysis.
Hematological parameters; hemoglobin (Hgb), hematocrit
(%), mean cell volume (MCV), mean cell hemoglobin
(MCH), mean cell hemoglobin concentration (MCHC),
red blood cell count (RBC) and red cell distribution width
(RDW) were determined using the automated blood
analyzer Cell-Dyne 1800 and CD4 count was assayed
using the Becton Dickenson (BD) FACS caliber. For intes-
tinal parasite examination a stool sample was collected
and a drop of saline was mixed by an applicator stick on
the slide and was examined for intestinal parasites by ex-
perienced laboratory technologist.
Table 1 Characteristics of HIV positive children attending
Gondar university hospital ART clinic from February to June,
2013, Northwest Ethiopia
Characteristics Frequency Percentage
Age in years 0.5–4.9 24 9.1
5–11.9 163 61.5
12–14.9 78 29.4
Sex Male 134 50.6
Female 131 49.4
Residence Urban 250 94.3
Rural 15 5.7
Religion of guardian Orthodox 233 87.92
Muslim 29 10.94
Protestant 3 1.13
Occupation of
guardian
Merchant 47 17.7
Farmer 23 8.7
Government employed 49 18.5
Non-employed 33 12.5
Daily laborer 113 42.6
Educational status
of guardian
Illiterate 78 29.4
Elementary School 97 36.6
High School 63 23.8
Certificate and above 27 10.2
Meat and animal
products intake
Yes 199 75.1
No 66 24.9
Green leafy
vegetables intake
Yes 219 82.6
No 46 17.4
WHO stage I 63 23.8
II 72 27.2
III 105 39.6
IV 25 9.4
HAART Yes 188 70.9
No 77 29.1
Opportunistic
infections
Yes 19 7.2
No 246 92.8
Cotrimoxazole Yes 129 48.7
No 136 51.3
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The data was cleaned, edited, checked for completeness
and entered in to the data program SPSS version 20 stat-
istical software for analysis. Descriptive statistics were
used to give a clear picture of dependent and independ-
ent variables. Bivariate and multivariate logistic regres-
sion was used to identify predictors.
Ethical clearance
The study was conducted after ethical letters were ob-
tained from university of Gondar Ethical Committee. In-
formed written consent was taken from the caretakers
and in addition assent was obtained from older children
(above 8 years) before enrollment in the study. Then the
objective of this research was explained to the study par-
ticipant’s, and those willing to participate were included.
Participation in the study was voluntary and refusal was
possible. To ensure confidentiality of data, study subjects
were identified using codes and unauthorized persons
were not able to access the collected data. The study
participants’ result were reported to the physician for
proper management.
Results
Socio-demographic and clinical characteristics of study
participants
A total of 264 HIV positive children, aged between
6 months and 14 years old, participated in the study.
One hundred thirty four were males and one hundred
thirty one were females, M:F was almost 1:1 (50.6 and
49.4 % respectively). The mean age of the study partici-
pants was 9.3 ± 3.3 years. The biggest percentage (61.9 %)
of children were aged 5 to 11.9 years. About 48.7 % were
receiving cotrimoxazole prophylaxis and 70.9 % were on
antiretroviral therapy (Table 1).
Prevalence of anemia
The prevalence of anemia among the study children was
obtained by considering the cut off values of Hgb
(<11 g/dl for children <5 years old, <11.5 g/dl for children
5–11.9 years old and <12 g/dl for children 12–14.9 years
old) after altitude adjustments. The study area has an alti-
tude of 2133 m and Hgb value was adjusted by subtracting
0.08 g/dl [3]). Based on this, prevalence of anemia was
16.2 % (43 /265). From the anemic children, 60.5 % of them
had mild anemia, 37.2 % had moderate anemia and 2.3 %
had severe anemia. Regarding the type of anemia, about
46.5 % of anemic children had normocytic-normochromic
anemia followed by macrocytic-normochromic anemia
(39.5 %) (Fig. 1).
To determine risk factors of anemia among HIV in-
fected children, the bivariate and multivariate logistic re-
gression was used to identify predictors. Based on this,
anemia was associated with eating green leafy vegetablesand taking cotrimoxazole treatment. But there was no
significant association between anemia and socio-
demographic characteristics, CD4 count, WHO clinical
stage, parasitic infections and OPIs (Table 2).Discussion
Anemia is a frequently encountered aberration in HIV pa-
tients [22] which may be clinically important. Multifactorial
Table 2 Association of socio-demographic and other clinical variables with anemia among HIV infected children attending Gondar
university Hospital ART clinic from February – June, 2013
Variables Anemic Non-anemic COR (95 % CI) AOR (95 % CI)
Age 0.5–5years 4 (16.7 %) 20 (83.3 %) 1 (0.293–3.413) 1.388 (0.359–5.363)
5–11years 26 (16.0 %) 137 (84.0 %) 1.054 (0.509–2.183) 1.285 (0.590–2.7980)
11–14years 13 (16.7 %) 65 (83.3 %) 1a 1a
Sex Male 20 (14.9 %) 114 (85.1 %) 1a 1a
Female 23 (17.6 %) 108 (82.4 %) 0.824 (0.428–1.585) 0.741 (0.358–1.530)
Eating animal products Yes 28 (14.1 %) 171 (85.9 %) 1a
No 15 (22.7 %) 51 (77.3 %) 0.557 (0.276–1.122)
Eating green leafy vegetable Yes 31 (14.2 %) 188 (85.8 %) 1a 1a
No 12 (26.1 %) 34 (73.9 %) 0.467 (0.219–0.999) 0.430 (0.188–0.981)
WHO Clinical stage I 15 (23.8 %) 48 (76.2 %) 1a 1a
II 11 (15.3 %) 61 (84.7 %) 1.733 (0.73–4.116) 1.886 (0.758–4.689)
III 16 (15.2 %) 89 (84.8 %) 1.738 (0.791–3.819) 1.497 (0.557–4.022)
IV 1 (4.0 %) 24 (96.0 %) 7.5 (0.934–60.196) 4.806 (0.547–42.203)
HAART Yes 24 (12.8 %) 164 (87.2 %) 1a 1a
No 19 (24.7 %) 58 (75.3 %) 0.447 (0.228–0.875) 0.671 (0.272–1.652)
Opportunistic infections Yes 6 (31.6 %) 13 (68.4 %) 0.384 (0.137–1.073) 0.416 (0.131–1.319)
No 37 (15.0 %) 209 (85.0 %) 1a 1a
Cotrimoxazole Yes 27 (20.9 %) 102 (79.1 %) 1a 1a
No 16 (11.8 %) 120 (88.2 %) 1.985 (1.014–3.889) 2.169 (1.047–4.490)
Intestinal parasite infection Yes 10 (15.4 %) 55 (84.6 %) 1.087 (0.503–2.348) 0.841 (0.373–1.895)
No 33 (16.5 %) 167 (83.5 %) 1a 1a
CD4 percentage <15 % 9 (18.8 %) 39 (81.2 %) 0.744 (0.306–1.81) 0.956 (0.341–2.686)
15–25 % 17 (16.8 %) 84 (83.2 %) 0.848 (0.408–1.765) 1.022 (0.455–2.293)
>25 % 17 (14.7 %) 99 (85.3 %) 1a 1a
aReference category, bold numeric indicates statistically significant association
Fig. 1 Type of anemia among HIV positive children attending Gondar University Hospital ART Clinic from February – June, 2013, Northwest Ethiopia
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its suitable treatment [23]. The pathogenesis of anemia in
HIV infection is multifactorial which includes bleeding
(gastrointestinal malignancy/severe infection), insufficient
dietary intake (vitamins such as cobalamin and folate, iron,
and general malnutrition), hemolytic anemia (i.e., malignan-
cies, infections, splenomegaly, and immune dysfunction)
and changes in erythropoietin synthesis and/or bone mar-
row suppression [2].
The prevalence of anemia in this study was 43/265
(16.2 %). This is lower than the reports of studies done
in India [24], Cape Town [25], Uganda [11], Tanzania
[26] and Jimma [18] which were 66, 73, 91.7, 21.9 and
44 %, respectively. On the other hand, it is higher than
the study done in Northwest Brazil 13.6 % [27]. This dif-
ference may be due to differences in ethnicity, geograph-
ical location, study designs and time of study. Also there
are age differences in the study participants, some took up
to 12 years old children, some up to 10 years old children
but the current study took children up to 14 years old.
In this study from anemic children, 60.5 % of them
had mild anemia, 37.2 % moderate anemia and 2.3 %
had severe anemia which is comparable with the
study done in Uganda in 2002 [11] where they re-
ported 35.1 % prevalence of moderate to severe
anemia and from 2007 to 2009 [28] which showed
62.2 % patients had mild anemia and 32.0 % had
moderate anemia while 4.8 % had severe anemia. In
contrast, prevalence of severe life threatening anemia
in our study, which was 2.3 %, was lower than study
done in Jimma, which was 14.3 % [18].
In the current study about 46.5 % of anemic children
had normocytic-normochromic anemia followed by
macrocytic-normochromic anemia (39.5 %). But in
Uganda [28] from 2007 to 2009 the predominant type of
anemia was microcytic-hypochromic anemia (44.9 %)
followed by normocytic-hypochromic anemia (26.5 %)
and normocytic-normochromic anemia (19.0 %).
In this study, anemia was associated with eating
green leafy vegetables and being on cotrimoxazole
treatment. But there is no significant association with
age, sex, residence, WHO clinical stage, HAART, op-
portunistic infections, intestinal parasitic infection and
CD4 percentage. But in contradiction to this study, a
study done in Tanzania showed that not being on
HAART, having CD4 % <25 %, having a history of tu-
berculosis and having hookworm infestation, were in-
dependent risk factors for anemia [26]. A similar study
on children aged 1 to 12 years in India, showed that
age younger than 6 years old, rural residence, advanced
HIV disease stage and TB infection were risk factors
for anemia while HAART was protective while gender,
cotrimoxazole and HAART regimen type had no asso-
ciation with anemia [24].Conclusion
Our findings showed that majority of HIV positive chil-
dren in Northwest Ethiopia who are anemic have mild
anemia and the prevalence of anemia is related to being
on cotrimoxazole and eating leafy vegetables. Therefore,
early diagnosis and treatment of anemia is essential in
these patients. In this study direct wet mount was used
for parasitic examination and this may less sensitive to
detect ova of parasites. Also longitudinal studies on iron,
folate, cobalamin levels and bone marrow examination,
erythropoietin and viral load determination, are needed
to determine the actual etiology of anemia in HIV in-
fected children.
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